Back to results
CompletedPhase 4

Comparison of Exenatide vs. Biphasic Insulin Aspart 30 on Glucose Variability in Type 2 Diabetes

NCT02449603

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Xijing Hospital, Fourth Military Medical university

Xi'an, Shaanxi, China

View on ClinicalTrials.gov
Comparison of Exenatide vs. Biphasic Insulin Aspart 30 on Glucose Variability in Type 2 Diabetes — TrialFind